This site uses cookies. For more information, please see our
Privacy Policy
Agree
About
Company
Board
Management
Products
Trogarzo® IV Infusion
Trogarzo® IV Push
TMB-365
TMB-365/TMB-380 (TMB-365 and TMB-380 combination)
Antibody-Drug Conjugates, ADCs
CDMO Service
Contract Development and Manufacturing Service (CDMO)
Partners
News
Activity
Investor Relations
Company
Company Profile
Company Presentation
Corparate Governance
Organization
Board
Committee
Internal Audit
Major Internal Policies
Financials
Monthly Revenue
Financial Reports
Shareholders' Services
Major Shareholders
Dividend Information
Shareholder's Meeting
Sustainable Development
2023 ESG
MENU
(
En
)
En
繁中
Contact CDMO Service
CLOSE
En
繁中
About
Company
Board
Management
Products
Trogarzo® IV Infusion
Trogarzo® IV Push
TMB-365
TMB-365/TMB-380 (TMB-365 and TMB-380 combination)
Antibody-Drug Conjugates, ADCs
CDMO Service
Contract Development and Manufacturing Service (CDMO)
Partners
News
Activity
Investor Relations
Company
Company Profile
Company Presentation
Corparate Governance
Organization
Board
Committee
Internal Audit
Major Internal Policies
Financials
Monthly Revenue
Financial Reports
Shareholders' Services
Major Shareholders
Dividend Information
Shareholder's Meeting
Sustainable Development
2023 ESG
2023
Home
News
Event information
2023
News
Recent News
2024
2023
Event information
2024
2023
Recent News > 2024
Recent News > 2023
Event information > 2024
Event information > 2023
2023/09/30
TaiMed at Bio-Japan 2023: Pioneering Innovation in HIV Therapy
2023/05/24
TaiMed will participate in the 2023 Bio International Convention in North America.
2023/05/12
2023 Shareholders' Meeting Video Recording
2023/02/02
TaiMed will participate in BioEuropeSpring 2023.